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Abstract
Background: Chromatin binding plays a central role in the molecular mechanism of LEDGF/p75 in HIV-1 DNA
integration. Conflicting results have been reported in regards to the relevance of the LEDGF/p75 chromatin
binding element PWWP domain in its HIV-1 cofactor activity.
Results: Here we present evidence that re-expression of a LEDGF/p75 mutant lacking the PWWP domain (ΔPWWP)
rescued HIV-1 infection in cells verified to express background levels of endogenous LEDGF/p75 that do not
support efficient HIV-1 infection. The HIV-1 cofactor activity of LEDGF/p75 ΔPWWP was similar to that of LEDGF/p75
wild type (WT). A possible molecular explanation for the nonessential role of PWWP domain in the HIV-1 cofactor
activity of LEDGF/p75 comes from the fact that coexpression of HIV-1 integrase significantly restored the impaired
chromatin binding activity of LEDGF/p75 ΔPWWP. However, integrase failed to promote chromatin binding of a
non-chromatin bound LEDGF/p75 mutant that lacks both the PWWP domain and the AT hook motifs (ΔPWWP/AT)
and that exhibits negligible HIV-1 cofactor activity. The effect of integrase on the chromatin binding of LEDGF/p75
requires the direct interaction of these two proteins. An HIV-1 integrase mutant, unable to interact with LEDGF/
p75, failed to enhance chromatin binding, whereas integrase wild type did not increase the chromatin binding
strength of a LEDGF/p75 mutant lacking the integrase binding domain (ΔIBD).
Conclusions: Our data reveal that the PWWP domain of LEDGF/p75 is not essential for its HIV-1 cofactor activity,
possibly due to an integrase-mediated increase of the chromatin binding strength of this LEDGF/p75 mutant.
Background
LEDGF/p75 is a cellular cofactor for HIV-1 DNA inte-
gration [1-3] and also participates in the MLL/menin-
mediated transcriptional regulation of Hox genes [4].
The HIV-1 cofactor activity of LEDGF/p75 requires its
simultaneous engagement with the host chromatin and
the viral enzyme integrase. LEDGF/p75 mutants that
lack their chromatin- or integrase-binding activity are
severely defective in their HIV-1 cofactor function [1,2].
Substitution of the chromatin binding domain of
LEDGF/p75 by heterologous chromatin binding domains
results in proteins that support HIV-1 DNA integration
[5-7]. However, the HIV-1 DNA integration site distri-
bution observed in LEDGF/p75-deficient cells expressing
these chimeras is altered and determined by the specifi-
city of the added chromatin binding domain [5,6]. These
results suggest that the role of the LEDGF/p75 chroma-
tin-binding domain is to provide a tight interaction to
the pre-integration complex with the host chromatin.
LEDGF/p75 persists tightly bound to chromatin during
all the phases of the cell cycle [8-10]. The chromatin bind-
ing activity of LEDGF/p75 is primarily mediated by the
functional interaction of the PWWP domain and the AT
hook motifs [1,2,7,8,11]. Simultaneous deletion of PWWP
domain and AT hook motifs abolished LEDGF/p75 chro-
matin binding during all the phases of the cellular life
cycle [8]. However, deletion of only the AT hook motifs
did not alter LEDGF/p75 chromatin binding, while dele-
tion of the PWWP domain decreased the strength of this
interaction during interphase and abolished the binding to
condensed chromatin during mitosis [7,8,12]. To a mark-
edly lesser extent, the nuclear localization signal and the
CR2 and CR4 regions also contribute to the overall bind-
ing of LEDGF/p75 to chromatin [11,13].
It is thought that PWWP determines the specificity of
the genome-wide location of LEDGF proteins by
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tion of the PWWP domain with chromatin seems to be
mediated by a solvent-exposed hydrophobic cavity in
this domain [15]. Mutation of the conserved residue
W21, located in this solvent-exposed hydrophobic cav-
ity, impairs the binding of LEDGF/p75 to chromatin
during all phases of the cellular life cycle [15], mimick-
ing the lack of the entire PWWP domain. Mutations of
W21 also affect the LEDGF/p75-mediated recruitment
of menin/MLL complex to Hox genes [4]. Whether or
not the PWWP domain of LEDGF/p75 is required for
its HIV-1 cofactor activity in the absence of other het-
erologous chromatin binding domains is still controver-
sial [7,14,15]. Stable re-expression of a LEDGF/p75
ΔPWWP mutant in human LEDGF/p75-deficient CD4+
cells was reported to rescue HIV-1 infection exhibiting
approximately 50% of the HIV-1 cofactor activity of
LEDGF/p75 WT [7]. However, very low (20.6%) or no
HIV-1 cofactor activity (≤0.1%) was observed upon tran-
sient expression of LEDGF/p75 ΔPWWP in different
LEDGF/p75 null mouse fibroblast cell lines [15]. Unex-
pectedly, in these experiments several LEDGF/p75
PWWP domain point mutants were significantly less
active than a LEDGF/p75 mutant lacking the entire
PWWP domain [15].
A potential explanation for the discrepancy observed
in the HIV-1 cofactor activity of LEDGF/p75 ΔPWWP
in human and mouse cells could be that the human
LEDGF/p75-deficient cells used in these experiments
have regained the ability to express endogenous
LEDGF/p75 and this event went unnoticed. These cells
were rendered LEDGF/p75-deficient by stable expres-
sion of a specific shRNA and were subsequently engi-
neered to stably express LEDGF/p75 ΔPWWP, by
transduction with a murine leukemia virus (MLV)-
derived viral vector followed by selection, in the pre-
sence of G418 [1]. During this process, it is possible
that a subpopulation of cells coexpressing endogenous
LEDGF/p75 and LEDGF/p75 ΔPWWP was selected.
Although expression of endogenous LEDGF/p75 was
excluded by immunoblotting analysis [7], LEDGF/p75
levels undetectable by sensitive immunoblots can still
mediate HIV-1 DNA integration [1]. This possibility is
definitively excluded in the mouse LEDGF/p75 knockout
cells.
We have re-evaluated the role of the PWWP domain
o fL E D G F / p 7 5i nH I V - 1i n f e c t i o nu s i n gh u m a nC D 4 +
LEDGF/p75-deficient cells. Our data indicate that the
PWWP domain of LEDGF/p75 is not essential for its
HIV-1 cofactor activity in cells expressing endogenous
levels of LEDGF/p75 that do not support HIV-1 infec-
tion. In addition, we have found that HIV-1 integrase
enhances the chromatin binding activity of LEDGF/p75
ΔPWWP during all the phases of the cell cycle. This
effect requires the direct interaction of LEDGF/p75 and
HIV-1 integrase. We postulate that the enhancing effect
of integrase on the chromatin binding activity of
LEDGF/p75 ΔPWWP significantly contributes to the
conserved HIV-1 cofactor activity of this mutant.
Results
The PWWP domain of LEDGF/p75 is not essential for
HIV-1 infection
In order to evaluate the role of the PWWP domain in
the HIV-1 cofactor activity of LEDGF/p75, we engi-
neered human LEDGF/p75-deficient CD4+ T cells, TL3
cells, to express C-terminally FLAG tagged LEDGF/p75
ΔPWWP. Expression of the LEDGF/p75 ΔPWWP in
these cells was achieved by transduction with an MLV-
derived viral vector and verified by immunoblotting
(Figure 1a). To further confirm the identity of the re-
expressed LEDGF/p75 mutant, genomic DNA was iso-
l a t e df r o mo n eT L3 LEDGF/p75 ΔPWWP cell line and
MLV-derived LEDGF/p75 cDNA was amplified by PCR
using primers that hybridize on the MLV genome and
on the LEDGF/p75 coding sequence. To avoid detection
of non-integrated MLV-delivered LEDGF/p75 ΔPWWP,
the analyzed cells were cultured in the selection medium
for more than six weeks after MLV-transduction. Using
this approach, a DNA fragment of the expected size for
the MLV-delivered LEDGF/p75 ΔPWWP cDNA was
obtained and its identity verified by DNA sequencing
(Data not shown). However, no other DNA fragments
indicative of the existence of others MLV-delivered
LEDGF/p75 cDNAs in the genome of TL3 LEDGF/p75
ΔPWWP cells were observed in these experiments, con-
firming that the LEDGF/p75 expressed in these cells
lack the PWWP domain.
TL3,T L3 LEDGF/p75 WT and TL3 LEDGF/p75
ΔPWWP cells were challenged with a single-round
infection HIV-1 luciferase reporter virus (HIVluc) and
infectivity was estimated by measuring luciferase five
days later. To ensure reproducibility, four independent
infections using two different viral doses, one ten fold
higher than the other, were considered. A total of eleven
independently derived TL3 LEDGF/p75 ΔPWWP cell
lines were evaluated in these experiments. We observed
that stable expression of LEDGF/p75 ΔPWWP in TL3
cells rescued HIV-1 infection by 27.8 +/- 5.5 fold
(Figure 1a). Similar susceptibility to HIV-1 infection was
observed in TL3 cells engineered to express LEDGF/p75
WT (26.7 +/- 2.06). No differences in the capability of
LEDGF/p75 ΔPWWP to rescue HIV-1 infection in TL3
cells were observed when cells were challenged with two
different amounts of viruses.
The HIV-1 cofactor activity of LEDGF/p75 ΔPWWP
reported here is higher than the previously observed in
TL3 cells stably expressing this mutant, found to be
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ever, both data sets clearly indicate that the PWWP
domain is not essential for LEDGF/p75 HIV-1 cofactor
activity. These findings in human CD4+ cells notor-
iously contrast with the required role observed in
LEDGF/p75 null mouse fibroblasts transiently trans-
fected with LEDGF/p75 ΔPWWP [15]. Interestingly,
variability in the HIV-1 cofactor activity of LEDGF/p75
ΔPWWP (≤0.1% to 20.6% of the WT activity) was also
observed when different LEDGF/p75 null mouse fibro-
blast cell lines were used [15].
A possible explanation for the observed differences in
the HIV-1 cofactor activity of LEDGF/p75 ΔPWWP is
the existence of different levels of endogenous LEDGF/
p75 in the studied cell lines. LEDGF/p75-deficiency was
achieved in TL3 cells by stable shRNA mediated-knock-
down and therefore during the process of generating TL3
LEDGF/p75 ΔPWWP a decrease in the shRNA levels
could have occurred, regaining these cells functional
levels of endogenous LEDGF/p75. This possibility is
excluded in the case of the LEDGF/p75 null mouse fibro-
blasts. In order to evaluate this hypothesis, we deter-
mined the levels of endogenous LEDGF/p75 in TL3,T L3
LEDGF/p75 WT and TL3 LEDGF/p75 ΔPWWP cells by
real time PCR. In correlation with previous data [1], we
o b s e r v e dm o r et h a n9 7 %r e d u c t i o ni nt h ee n d o g e n o u s
levels of LEDGF/p75 in TL3 cells as compared to TC3
control cells (Figure 1b). Importantly, more than 97%
reduction of endogenous levels of LEDGF/p75 was also
observed in both TL3 LEDGF/p75 WT and TL3 LEDGF/
p75 ΔPWWP cells, supporting the notion that the sus-
ceptibility of TL3 LEDGF/p75 ΔPWWP cells to HIV-1
infection was not determined by the existence of func-
tional amounts of endogenous LEDGF/p75. Therefore,
data in figure 1 indicate that the PWWP domain is not
essential for the HIV-1 cofactor activity of LEDGF/p75.
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Figure 1 HIV-1 cofactor activity of LEDGF/p75 ΔPWWP.( a )T L3,a n dT L3 cells expressing LEDGF/p75 WT or LEDGF/p75 ΔPWWP (eleven
different cell lines) were challenged with HIVluc and luciferase activity determined five days later. Expression of LEDGF/p75 proteins in these cell
lines was documented by immunoblotting with an anti-LEDGF and anti-FLAG Mabs. Errors bars correspond to four independent infection
experiments. (b) LEDGF/p75 mRNA levels in TC3 and cells used in panel (a). The mRNA levels of endogenous LEDGF/p75 were quantified by real
time PCR using specific primers. mRNA levels for LEDGF/p75 were normalized to those of GAPDH in the same samples. Errors bars correspond to
triplicate real-time PCR measurements.
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p75 ΔPWWP
HIV-1 integrase binds to DNA [16,17], and LEDGF/p75
has been reported to increase the DNA binding affinity
of HIV-1 integrase in in vitro studies [18]. However, it
is unknown if integrase has any effect on the chromatin
binding activity of LEDGF/p75. Heterologous chromatin
binding domains act in cis to rescue the HIV-1 cofactor
activity of LEDGF/p75 mutants lacking the LEDGF/p75
chromatin binding domain [5-7]. Whether integrase can
act in trans to promote binding of LEDGF/p75
ΔPWWP to chromatin, resulting in preservation of its
HIV-1 cofactor activity, is unknown.
In order to evaluate this hypothesis, we determined
the chromatin binding strength of LEDGF/p75 WT and
ΔPWWP in LEDGF/p75-deficient cells co-expressing or
not co-expressing HIV-1 integrase. Because of the uni-
versal character of the cofactor role of LEDGF/p75 in
HIV-1 DNA integration (reviewed in [19-21]), we
decided to study the effect of HIV-1 integrase on the
chromatin binding activity of LEDGF/p75 in LEDGF/
p75-deficient HEK293T cells (si1340/1428) [22].
LEDGF/p75 WT or mutants, alone or in combination
with HIV-1 integrase, were stably expressed in si1340/
1428 cells; and the LEDGF/p75 chromatin binding
strength was determined using the salt extraction assay
[13]. In the absence of HIV-1 integrase, around 70% of
LEDGF/p75 WT was extracted from chromatin at NaCl
concentrations above 200 mM. However, this salt con-
centration extracted less than 1% of LEDGF/p75 WT in
cells co-expressing HIV-1 integrase and LEDGF/p75
WT (Figure 2a and 2b). A similar enhancing effect of
HIV-1 integrase on the chromatin binding strength of
LEDGF/p75 ΔPWWP was observed. In cells expressing
LEDGF/p75 ΔPWWP in the absence of HIV-1 integrase,
30% and 70% of LEDGF/p75 ΔPWWP protein was
extracted at 100 mM and 150 mM NaCl, respectively
( F i g u r e2 aa n d2 b ) .H o w e v e r ,a tt h e s es a l tc o n c e n t r a -
tions, less than 2% of the LEDGF/p75 ΔPWWP was
extracted from cells coexpressing LEDGF/p75 ΔPWWP
and HIV-1 integrase (Figure 2a and 2b).
We further evaluated the effect of HIV-1 integrase on
LEDGF/p75 ΔPWWP chromatin binding by performing
a chromatin binding assay [8]. Using this assay, it has
been previously demonstrated that LEDGF/p75 ΔPWWP
equally distributes in the non-chromatin bound (S1) and
chromatin bound (P1 and S2) fractions [7,8]. In order to
obtain a more defined distribution pattern of LEDGF/p75
ΔPWWP among these subcellular fractions, we increased
the NaCl concentration of the initial lysis buffer (CSK I
buffer) from 100 mM to 150 mM (CSK I-150 buffer). In
correlation with the results obtained with the salt extrac-
tion assay (Figure 2a and 2b), we found that in the
absence of HIV-1 integrase, LEDGF/p75 ΔPWWP was
significantly extracted in the S1 fraction when cells were
lysed in the CSK I-150 buffer (Figure 2c). However, in
cells co-expressing HIV-1 integrase, LEDGF/p75
ΔPWWP was only minimally extracted in the non-chro-
matin bound fraction (S1), while the majority of protein
was detected in the chromatin bound fractions (P1 and
S2) (Figure 2c). As expected, LEDGF/p75 WT was pre-
sent exclusively in the chromatin bound fractions when
cells were lysed in the presence of 150 mM NaCl (Figure
2c). In summary, results in figure 2 indicated that HIV-1
integrase increases the binding strength of LEDGF/p75
to chromatin.
The enhancing effect of integrase on LEDGF/p75
chromatin binding activity requires the direct interaction
of these two proteins
In order to evaluate the role of direct protein interaction
on the ability of integrase to enhance chromatin binding
of LEDGF/p75, we investigated HIV-1 integrase and
LEDGF/p75 mutants that fail to reciprocally interact.
HIV-1 integrase Q168L mutant [23,24] and a LEDGF/
p75 lacking the integrase-binding domain (ΔIBD) were
evaluated. In these experiments, FLAG-tagged LEDGF/
p75 WT, ΔPWWP, or ΔIBD were transiently coex-
pressed in HEK293T LEDGF/p75-deficient cells alone or
with Myc-eGFP-tagged HIV-1 integrase WT or Q168L
mutant and the chromatin binding strength of LEDGF/
p75 evaluated as described in Figure 2a.
In agreement with our observations in cells stably co-
expressing LEDGF/p75 and HIV-1 integrase (Figure 2),
transient coexpression of HIV-1 integrase WT increased
the chromatin binding activity of LEDGF/p75 WT
(Figure 3a) and ΔPWWP (Figure 3b). In the absence of
integrase, transiently expressed LEDGF/p75 WT was
completely extracted at 250 mM NaCl whereas more
than 300 mM NaCl was required to extract LEDGF/
p75 WT when HIV-1 integrase WT was coexpressed
(Figure 3a). However this effect of integrase was not
observed after cotransfection of HIV-1 integrase Q168L
and LEDGF/p75 WT. Similarly, LEDGF/p75 ΔPWWP
was partially extracted at 100 mM NaCl and required
150 mM NaCl for total extraction in the absence of HIV-
1 integrase, whereas when cotransfected with the WT
viral protein this LEDGF/p75 mutant was only extracted
partially at 150 mM NaCl and required above 200 mM
NaCl for complete extraction from chromatin (Figure
3b). On the contrary, co-expression of HIV-1 integrase
Q168L mutant with LEDGF/p75 ΔPWWP (Figure 3b)
did not increase its chromatin binding activity. The
inability of the integrase Q168L mutant to increase the
chromatin binding strength of LEDGF/p75 WT or
ΔPWWP indicated that the effect of HIV-1 integrase on
LEDGF/p75 chromatin binding requires the direct inter-
action of these two proteins. In further support of this
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WT was unable to enhance the chromatin binding activ-
ity of a LEDGF/p75 ΔIBD (Figure 3c). In the presence or
in the absence of HIV-1 integrase WT, LEDGF/p75
ΔIBD was partially extracted from chromatin at 150 mM
NaCl and required more than 200 mM NaCl to be com-
pletely extracted (Figure 3c).
The inability of HIV-1 integrase proteins to enhance
the chromatin binding activity of LEDGF/p75 proteins
in some of the experiments represented in Figure 3a - c
was not due to poor expression of the integrase pro-
teins, as demonstrated by anti-Myc immunoblotting
(Figure 3d). Data in Figure 3d indicate that similar levels
of integrase WT or Q168L were observed in cells
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Figure 2 Effect of HIV-1 integrase on the chromatin binding activity of LEDGF/p75. (a) The chromatin binding strength of LEDGF/p75 WT
and ΔPWWP was determined by the salt extraction method using LEDGF/p75-deficient HEK293T cells stably expressing these LEDGF/p75
proteins alone or together with Myc-tagged HIV-1 integrase. Immunoblots show the amount of LEDGF/p75 extracted from chromatin at different
concentrations of NaCl as detected with an anti-LEDGF Mab. T represents a total cellular lysate obtained by boiling the cells in Laemmli buffer.
(b) The intensity of different immunoblot bands in panel (a) was quantified by densitometry analysis and expressed as percentage of the
intensity of the bands corresponding to the total cellular lysate (T). Errors bars were calculated using two different experiments. (c) Chromatin
binding assay. The subcellular distribution of LEDGF/p75 WT or ΔPWWP mutant was evaluated by immunoblotting with an anti-LEDGF Mab in
cells stably expressing these LEDGF/p75 proteins alone or together with Myc-tagged HIV-1 integrase. S1 and P2 are non-chromatin bound
fractions; P1 and S2 are chromatin-bound fractions, and T is a total cellular lysate. The S1 fraction was obtained by lysing the cells in CSK I buffer
containing 150 mM NaCl.
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Page 5 of 14analyzed in Figure 3a - c. These results correlated with
the similar levels of green fluorescence detected by
fluorescence microscopy analysis in the studied cells
(not shown).
HIV-1 integrase allows binding of LEDGF/p75 ΔPWWP to
mitotic chromatin
Previous studies have shown that deletion of the PWWP
domain in LEDGF/p75 blocks its binding to chromatin
during mitosis, indicating that this domain, but not
other chromatin binding elements in LEDGF/p75, med-
iates binding to mitotic condensed chromatin [7,8,12].
In order to evaluate whether HIV-1 integrase can also
enhance the binding of LEDGF/p75 ΔPWWP to mitotic
chromatin, the subcellular distribution of this mutant
was determined in LEDGF/p75-deficient cells coexpres-
sing HIV-1 integrase by immunofluorescence.
Immunostaining of LEDGF/p75-deficient cells coex-
pressing LEDGF/p75 ΔPWWP and eGFP-tagged HIV-1
integrase indicated that these two proteins colocalized at
the nucleus during interphase and on mitotic chromo-
somes (Figure 4a-i). A comparable distribution was
observed in cells coexpressing LEDGF/p75 WT and
HIV-1 integrase (Figure 4a-ii). These observations indi-
cated that binding of HIV-1 integrase to LEDGF/p75
ΔPWWP promotes the interaction of this complex with
chromatin during mitosis.
Similar results were found using the integrase to chro-
matin tethering assay [13] where we used LEDGF/p75-
deficient cells that stably express eGFP-tagged HIV-1
integrase. In these cells, eGFP-integrase has a pancellu-
lar distribution [13]. However, upon transient expression
of LEDGF/p75 WT, the viral protein accumulated in the
nuclei of cells in interphase and was associated with
NaCl (mM)
T      200  250  300   350  500
70 kDa WT
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d
Figure 3 Effect of HIV-1 integrase Q168L mutant on the chromatin binding activity of LEDGF/p75. Immunoblots show the effect of
transient expression of HIV integrase WT and Q168L mutant on the chromatin binding strength of LEDGF/p75 WT (a) and LEDGF/p75 ΔPWWP
(b), and the effect of HIV-1 integrase WT on the chromatin binding strength of LEDGF/p75 ΔIBD (c). LEDGF/p75 was detected with an anti-FLAG
Mab. Immunoblots in (d) show the level of expression of HIV integrase WT and Q168L in cells coexpressing LEDGF/p75 WT, LEDGF/p75 ΔPWWP,
and LEDGF/p75 ΔIBD analyzed in the experiments represented in (a), (b), and (c), respectively. HIV-1 Integrase was detected with an anti-Myc
Mab. T represents a total cellular lysate.
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i). In contrast, expression of LEDGF/p75 ΔIBD did not
change the subcellular distribution of eGFP-integrase in
these cells (Figure 4b ii). Importantly, transient expres-
sion of LEDGF/p75 ΔPWWP caused a change in the
subcellular distribution of the eGFP-integrase that was
indistinguishable to the one observed upon expression
o fL E D G F / p 7 5W T( F i g u r e4 bi i i ) .T h e s ee v i d e n c e s
demonstrated that HIV-1 integrase promotes interaction
of LEDGF/p75 ΔPWWP with mitotic chromosomes.
HIV-1 integrase failed to promote chromatin binding of a
LEDGF/p75 ΔPWWP/AT mutant
Our results suggest that the enhancing effect of inte-
grase on the chromatin binding strength of LEDGF/p75
ΔPWWP could determine the wild type HIV-1 cofactor
activity of this mutant. For instance, integrase in the
HIV-1 pre-integration complex could enhance in trans
the chromatin binding of LEDGF/p75 ΔPWWP during
viral integration to levels that support full HIV-1 cofac-
tor activity. In this case we should expect that integrase
will fail to promote chromatin binding of the chromatin
binding defective mutant LEDGF/p75 ΔPWWP/AT
since this mutant is also very deficient in HIV-1 cofactor
activity [1,2]. Therefore, we explored the effect of integrase
on the chromatin binding properties of LEDGF/p75
ΔPWWP/AT using the salt extraction assay (Figure 5a).
LEDGF/p75 ΔPWWP/AT was fully extracted from chro-
matin at 100 mM NaCl in cells lacking HIV-1 integrase, as
previously reported [13]. Interestingly, this extraction
ii i
LEDGF/p75 ǻPWWP + eGFP-Integrase
Detection: LEDGF/p75 DAPI eGFP-Integrase
Transfection:
LEDGF/p75 DAPI eGFP-Integrase
LEDGF/p75 WT + eGFP-Integrase
ǻIBD
eGFP-integrase
DAPI
i ii iii
ǻPWWP WT Transfected LEDGF/p75:
Detection:
a
b
Figure 4 HIV-1 integrase promotes binding of LEDGF/p75 ΔPWWP to mitotic chromosomes. (a) Immunofluorescence analysis of LEDGF/
p75-deficient cells stably expressing eGFP-tagged HIV-1 integrase and transiently transfected with FLAG-tagged LEDGF/p75 WT (panel ii) or
ΔPWWP (panel i). LEDGF/p75 was detected with an anti-FLAG Mab, DAPI was used for detection of chromatin. (b) Integrase-to-chromatin
tethering assay. LEDGF/p75-deficient HEK293T cells stably expressing eGFP-tagged integrase were transiently transfected with LEDGF/p75 WT
(panel i) or the mutants ΔIBD (panel ii) and ΔPWWP (panel iii) and the subcellular distribution of eGFP-integrase determined by fluorescence
microscopy analysis.
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p75 ΔPWWP/AT and HIV-1 integrase, indicating that the
viral protein failed to promote chromatin binding of
LEDGF/p75 ΔPWWP/AT.
In correlation with the results obtained with the salt
extraction assay, LEDGF/p75 ΔPWWP/AT was exclusively
recuperated in the non-chromatin bound fraction (S1)
when cells were lysed in the presence of 150 mM NaCl
(CSK I-150) (Figure 5b). This subcellular distribution of
LEDGF/p75 ΔPWWP/AT was also observed in cells coex-
pressing HIV-1 integrase. Collectively, results in Figure 5
showed that HIV-1 integrase was unable to induce chro-
matin binding of LEDGF/p75 ΔPWWP/AT. Our results
also correlate with a previous report indicating that the
complex HIV-1 integrase-LEDGF/p75 ΔPWWP/AT does
not associate with mitotic chromosomes [7].
Effect of the ionic strength on the stability of the ternary
complex chromatin LEDGF/p75-HIV-1 integrase
The HIV-1 co-factor activity of LEDGF/p75 involves its
simultaneous interaction with the host chromatin and
with HIV-1 integrase [1,2]. To determine the effect of
the ionic strength on the interaction of HIV-1 integrase
with chromatin bound LEDGF/p75, we evaluated the
consequence of increasing concentrations of NaCl on
the chromatin binding of HIV-1 integrase (salt extrac-
tion assay).
HIV-1 integrase was fully extracted from chromatin at
NaCl concentrations of 250 mM, 200 mM and 100 mM
in cells coexpressing LEDGF/p75 WT, ΔPWWP and
ΔPWWP/AT, respectively (Figure 6a). Interestingly, the
extraction pattern of HIV-1 integrase was similar to the
one observed for the coexpressed LEDGF/p75 proteins
(Figure 2b and 5a). These observations suggest that
HIV-1 integrase lacks chromatin interaction upon
LEDGF/p75 chromatin detachment. Alternatively, the
interactions of LEDGF/p75 with integrase and LEDGF/
p75 with chromatin could be disrupted at a similar ionic
strength. To evaluate these hypotheses, we studied the
effect of NaCl concentration on the LEDGF/p75-HIV-1
integrase interaction using a non-chromatin bound
complex.
T    100  150  200   250  300   350  500
NaCl (mM)
70kDa
70kDa
LEDGF/p75 ǻ PWWP/ǻAT
LEDGF/p75 ǻ PWWP/ǻAT
Myc-Integrase
None
Immunoblot: anti-LEDGF
HIV-1 integrase coexpressed
70kDa
70kDa
S1     P1    S2   P2       T
LEDGF/p75 ǻ PWWP/ǻAT
LEDGF/p75 ǻ PWWP/ǻAT
Myc-Integrase
None
HIV-1 integrase coexpressed
Immunoblot: anti-LEDGF
a
b
Figure 5 Effect of HIV-1 integrase on the chromatin binding activity of LEDGF/p75 ΔPWWP/AT.( a )T h ec h r o m a t i nb i n d i n gs t r e n g t ho f
LEDGF/p75 ΔPWWP/AT was determined by the salt extraction assay in LEDGF/p75-deficient HEK293T cells stably expressing LEDGF/p75 ΔPWWP/
AT alone or together with Myc-tagged HIV-1 integrase. Immunoblots show the amount of LEDGF/p75 ΔPWWP/AT extracted from chromatin at
different salt concentrations as detected with an anti-LEDGF Mab. (b) Chromatin binding assay. The subcellular distribution of LEDGF/p75
ΔPWWP/AT was evaluated by cellular fractionation and immunobloting with anti-LEDGF Mab in cells stably expressing this LEDGF/p75 mutant
alone or together with Myc-tagged HIV-1 integrase. The S1 fraction was obtained by lysing the cells in CSK I buffer containing 150 mM NaCl. T,
S1, P1, S2, and P2 are described in figure legend 2.
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released from the chromatin by DNase and (NH4)2SO4
treatment and isolated by immunoprecipitation with an
anti-LEDGF/p75 Mab. The immunoprecipitated com-
plex attached to the immunobeads was further incu-
bated in CSK I buffer containing 0, 250 and 500 mM
NaCl and the presence of LEDGF/p75 and Myc-tagged
HIV-1 integrase in the eluate or bound to the immuno-
beads was evaluated by immunobloting. Results in
Figure 6b indicated that the LEDGF/p75-HIV-1 inte-
grase interaction is very stable, resisting the treatment
with 500 mM NaCl. The effect of higher salt concentra-
tions on the stability of this complex was not evaluated
since at 500 mM NaCl the antibody-LEDGF/p75 inter-
action began to be disrupted. Data in figure 6 demon-
strated that the chromatin-LEDGF/p75 interphase is
sustained by weaker interactions than the LEDGF/p75-
integrase in this ternary complex.
T    100  150   200   250  300   350  500
NaCl (mM)
25kDa
ǻPWWP
WT
25kDa
25kDa
LEDGF/p75 coexpressed
ǻPWWP/ǻAT
Integrase
Integrase
Integrase
Immunoblot: anti-Myc
0   250   500     0    250     500
NaCl (mM) 
70kDa
Immunoblot: anti-LEDGF/p75 and anti-Myc
J-chain Ig
Integrase
LEDGF/p75
light-chain Ig
25kDa
55kDa
Fractions:        Bound                 Eluate
a
b
Figure 6 Effect of the ionic strength on the stability of the ternary complex chromatin LEDGF/p75-HIV-1 integrase. (a) The chromatin
binding strength of the complex HIV-1 integrase-LEDGF/p75 was determined by the salt extraction method in LEDGF/p75-deficient HEK293T
cells stably coexpressing Myc-tagged integrase and LEDGF/p75 WT, ΔPWWP or ΔPWWP/AT. Myc-integrase was determined by immunoblotting
using an anti-Myc Mab. (b) Effect of salt concentration on the non-chromatin bound HIV-1 integrase-LEDGF/p75 complex. The integrase-LEDGF/
p75 complex bound to anti-LEDGF Mab coupled-magnetic beads was incubated in CSK I buffer supplemented with different NaCl
concentrations and LEDGF/p75 and integrase were determined by immunoblotting with anti-LEDGF and anti-Myc Mabs, respectively, in the
immunocomplex-bound to the magnetic beads or in the eluated fractions.
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Chromatin binding is central in the role of LEDGF/p75
in HIV-1 DNA integration [1,2,7]. Biochemical and cel-
lular biology evidences indicate that chromatin bound
LEDGF/p75 tethers integrase to the host chromatin sug-
gesting a cargo role for integrase during this process
[22,25]. Our data have expanded the understanding of
the interactions of the integrase-LEDGF/p75 complex
with chromatin showing an active role of integrase in
this association. We have shown evidences that the
chromatin binding strength of LEDGF/p75 WT and the
chromatin biding mutant LEDGF/p75 ΔPWWP is signif-
icatively enhanced upon direct interaction with HIV-1
integrase. Integrase also rescued the binding of the
LEDGF/p75 ΔPWWP mutant to mitotic chromosomes.
However, some degree of chromatin binding of LEDGF/
p75 is required for this enhancing effect of integrase,
s i n c et h ev i r a lp r o t e i nw a su n a b l et oi n d u c ec h r o m a t i n
binding of the LEDGF/p75 ΔPWWP/AT mutant that
does not interact with chromatin [8,12]. These observa-
tions indicate that LEDGF/p75 and integrase cooperate
in their binding to chromatin.
Due to the central role of chromatin binding in the
HIV-1 cofactor activity of LEDGF/p75, it is expected
that the HIV-1 cofactor activity of LEDGF/p75 ΔPWWP
mutant is impaired. However, conflicting results in
regards to the relevance of the PWWP domain in the
HIV-1 cofactor activity of LEDGF/p75 have been
reported. While this domain was found to be essential
for HIV-1 infection in LEDGF/p75-knockout mouse
fibroblast [15], its was dispensable in LEDGF/p75-
deficient human CD4+ T cells (this study and [7]). The
enhancing effect of integrase on the chromatin binding
strength of LEDGF/p75 could offer a molecular explana-
tion for the conserved HIV-1 cofactor activity of the
LEDGF/p75 ΔPWWP mutant observed in human cells.
It is possible that the chromatin binding strength of
LEDGF/p75 ΔPWWP is enhanced to levels that sustain
HIV-1 cofactor activity upon binding to the integrase in
the HIV-1 pre-integration complex. In support of this
hypothesis, HIV-1 integrase failed to promote chromatin
binding of LEDGF/p75 ΔPWWP/AT and this mutant
exhibits very poor HIV-1 cofactor activity. These evi-
dences indicate a direct correlation between the capabil-
ity of HIV-1 integrase to promote chromatin binding of
LEDGF/p75 mutants and their HIV-1 cofactor activity.
Integrase binds nonspecifically to DNA through its
C-terminal domain although all three integrase domains
interact with DNA (reviewed in [16,17]). The N-terminal
domain is located in close proximity to the integration tar-
get DNA whereas the catalytic core and the C-terminal
domains participate in binding to viral LTR DNA. In vitro
binding of LEDGF/p75 to HIV-1 integrase significantly
increases the affinity of the viral enzyme for DNA [18].
We speculate that the binding of integrase to LEDGF/p75
increases its affinity for DNA and subsequently integrase
enhances the binding of the LEDGF/p75-integrase com-
plex to chromatin. In support to our model, during the
preparation of this manuscript it was reported that HIV-1
integrase significantly enhances the affinity of LEDGF/p75
for chromatin as evaluated by quantitative fluorescence
microscopy techniques [26].
The impaired HIV-1 cofactor activity of LEDGF/p75
ΔPWWP observed in mouse [15] but not in human
cells (this study and [7]) could be a consequence of the
method employed to express the LEDGF/p75 PWWP
mutants in these cells. The LEDGF/p75 null mouse
fibroblasts expressing LEDGF/p75 PWWP mutants were
generated by transient coexpression of the mutant pro-
teins and eGFP followed by fluorescence-activated cell
sorting of the transfected cells [15], while the LEDGF/
p75-deficient human CD4+ T cells were engineered to
stably express the LEDGF/p75 mutant from the MLV
promoter ([7] and this report). Transient but not stable
expression, usually leads to protein overexpression.
Then, it is possible that the overexpressed LEDGF/p75
PWWP mutants accumulate in the cytoplasmic com-
partment of the transfected mouse fibroblasts as a result
of the saturation of the nuclear import pathway respon-
sible for the nuclear localization of these mutants [12].
Different from LEDGF/p75 WT that enters to the
nucleus via the nuclear import machinery during inter-
phase [12,27] and by interacting with condensed chro-
matin during mitosis [12], LEDGF/p75 ΔPWWP
depends exclusively on the nuclear import pathway to
gain nuclear access [12]. Therefore, LEDGF/p75
ΔPWWP overexpression could generate a pool of cyto-
plasmic LEDGF/p75 able to sequester incoming viral
pre-integration complexes in the HIV-1 challenged cells,
impairing in this manner viral infection. In support of
this mechanism, it has been demonstrated that other
non-chromatin bound IBD-containing proteins interact
with the integrase present in the incoming pre-integra-
tion complex in the cytoplasm compartment [28] block-
ing HIV-1 infection [1,7,7,28,29]. The generation of this
LEDGF/p75 cytoplasmic pool is unlikely to occur in the
absence of protein overexpression such as during LTR-
driven stably expression of LEDGF/p75 PWWP mutants
in the studied human cells. Variability in the levels of
overexpressed LEDGF/p75 PWWP mutants in the tran-
siently transfected mouse fibroblasts could also explain
the paradoxical observation that some LEDGF/p75
PWWP domain point mutants have a significantly lower
HIV-1 cofactor activity than mutants lacking the entire
PWWP domain [15].
The formation and stability of the ternary complex
chromatin LEDGF/p75-integrase are fundamental for
HIV-1 infection [1-3]. Based on the effect of the ionic
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that LEDGF/p75 establishes stronger interactions with
HIV-1 integrase than with chromatin. In addition to
binding to lentiviral integrases, LEDGF/p75 interacts
through IBD with cellular proteins including the Myc-
interactor protein JPO2 [30,31], the domesticated trans-
posase of the pogo transposable element with ZNF
domain (pogZ) [32], the menin/MLL histone methyl-
transferase complex [4] and the S-phase kinase Cdc7:
ASK heterodimer [33]. The surface of interaction of the
IBD with a subset of these proteins partially overlaps
with that of integrase (reviewed in [19]). The affinity of
IBD for integrase is higher than for some of these cellu-
lar proteins, explaining why they fail to restrict HIV-1
infection. The affinity of the catalytic core domain of
HIV-1 integrase for recombinant LEDGF/p75 was
approximately two-fold higher than that of pogZ or
JPO2, as calculated in an AlphaScreen interaction assay
[32]. Importantly, our data using LEDGF/p75-integrase
complex immunopurified from cells corroborate these
in vitro observations. We observed that the LEDGF/p75-
integrase complex was stable in the presence of up to
500 mM NaCl whereas 400 mM NaCl was reported to
significantly disrupt the interaction of LEDGF/p75 with
pogZ [32]. This evidence suggests that HIV-1 integrase
has evolved a high affinity surface of interaction with
IBD that allows the viral protein to out compete the
binding of other cellular IBD interactors.
In summary, our data indicate that HIV-1 integrase
modulates the chromatin binding strength of the inte-
grase-LEDGF/p75 complex and we propose that this
effect of integrase determines the nonessential role of
the PWWP domain of LEDGF/p75 in its HIV-1 cofactor
activity.
Conclusions
The new model that emerges from our study indicates
that HIV-1 integrase enhances LEDGF/p75 chromatin
binding during HIV-1 DNA integration and that this
effect has important functional implications for the
HIV-1 cofactor activity of LEDGF/p75.
Methods
Plasmids
LEDGF/p75 expression plasmids
pLEDGF/p75-IRES-Zeocin was used for stable expres-
sion of LEDGF/p75 WT or mutants in LEDGF/p75-defi-
cient HEK293T cells (si1340/1428 cell line) [22]. This
plasmid encodes a LEDGF/p75 cDNA linked to the
gene conferring resistance to Zeocin. The re-expressed
LEDGF/p75 contains seven synonymous mutations in
the target site of the twenty-one shRNA 1340 [22]. This
shRNA is present in all the LEDGF/p75-deficient cell
lines used in this report. LEDGF/p75 mutants were
generated on pLEDGF/p75-IRES-Zeocin with the Phu-
sion™ Site-Directed Mutagenesis Kit (Finnzymes, Inc),
as previously described [13]. The sequences of the speci-
fic primers used are available upon request. All the con-
structs described in this study were verified by
overlapping DNA sequencing of the complete LEDGF/
p75 cDNA.
HIV-1 integrase expression plasmids
pHIN [22] and pHIN-eGFP-IRES-P[13] are CMV-driven
expression plasmids that encode HIV-1 integrase
C-terminally tagged with Myc or Myc-eGFP, respectively.
Retroviral vector plasmids. Plasmids encoding single-
round infection HIV-1 luciferase reporter vector (pHIV-
luc [1]), LEDGF/p75-expression MLV-derived vector
(pJZLEDGF/p75 ΔPWWP [13]), and the Vesicular
Stomatitis Virus glycoprotein G (VSV-G) expression
plasmid pMD.G (a gift of D. Trono) were used for pro-
duction of retroviral vectors.
Cell lines
The human LEDGF/p75-deficient CD4+ T cell line, TL3
[1], was used for stable expression of LEDGF/p75
mutants while the TC3 cells expressing normal levels of
LEDGF/p75 were used as control in some experiments.
These cells were generatedb yt r a n s d u c t i o no fS u p T 1
cells with an HIV-derived vector expressing a shRNA
against LEDGF/p75 (TL3) or a control shRNA (TC3). TL3
cells express 97% less LEDGF/p75 mRNA than TC3 cells
as determined by real time PCR [1]. TL3 LEDGF/p75
ΔPWWP cells were generated by transduction with an
MLV-derived viral vector (pJZ308) harboring an expres-
sion cassette for this mutant and further selection in the
presence of G418, as previously described [1]. The
development and characterization of TL3 LEDGF/p75
WT cells was described before [13].
The LEDGF/p75-deficient HEK293T-derived cell line
si1340/1428 [22] and the LEDGF/p75-deficient HEK293T
cells expressing Myc-tagged HIV-1 integrase [13] were
used for stable expression of the LEDGF/p75 WT or the
deletion mutants ΔPWWP and ΔPWWP/AT. For genera-
tion of these stable cell lines, cells were plated at a density
of 3 × 10
6 in a 75-cm
2 flask and transfected by calcium-
phosphate the next day with 20 μg of the corresponding
expression plasmids pLEDGF/p75-IRES-Zeocin linearized
at the prokaryotic backbone. Stably transfected cells
were obtained after selection in the presence of zeocin
(150 ug/ml) and the expression of LEDGF/p75 WT and
mutants was verified by immunoblotting with an anti-
LEDGF/p75 Mab, as described below.
SupT1-derived cell lines were grown in RPMI1640
while HEK293T-derived cells were grown in DMEM
and both culture media were supplemented with 10%
heat-inactivated fetal calf serum, 2 mM L-glutamine and
1% penicillin/streptomycin.
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The level of endogenous mRNA LEDGF/p75 was quan-
tified in TC3,T L3 and TL3 cells expressing different
LEDGF/p75 proteins. Primers sense MB36 (5’ AGAT-
GAACTTCAGGGTCAGC 3’)a n da n t i s e n s eM B 6 0( 5 ’
GTTTTATTCGCTTCCTCATGCTGTCT 3’) were used
for detection of endogenous LEDGF/p75. Primer MB60
binds to a nucleotide sequence that is present in the
endogenous LEDGF/p75 mRNA but not in the MLV-
expressed LEDGF/p75 mRNA. This sequence was tar-
geted for mutagenesis in the MLV-expressed LEDGF/
p75 cDNA to prevent recognition of the encoded
mRNA by the LEDGF/p75-specific shRNA present in
TL3 cells. As a result, seven synonymous mutations were
introduced in this cDNA sequence avoiding binding of
MB60. Primer MB36 binds to a region in LEDGF/p75
that is present in both the endogenous and the MLV-
expressed LEDGF/p75 mRNAs. GAPDH mRNA levels
were quantified using primers sense JK9 (5’ CCCCTC
CTAGGCCTTTGC 3’) and antisense JK10 (5’ GCTGA-
GAGGCGGGAAAGTT 3’). Total RNA was extracted
from 4 × 10
6 cells using the RNeasy mini kit (Qiagen #
74104) and cDNA was generated from 2 μgo fR N A
with random oligonucleotides using the High Capacity
cDNA Reverse Transcription Kit (Applied Biosystems
#4368814). Quantitative real-time PCR was conducted
with 12.5 hg cDNA and 10 pM of the forward and
reverse primers. Primers were annealed at 64°C for
30 secs and extension was allowed for 30 secs at 72°C,
50 PCR cycles were performed. Ct values for LEDGF/
p75 and GAPDH were calculated comparing the results
obtained with each sample to results obtained with a
standard curve generated from a serial dilution of
human genomic DNA (1hg, 0.1hg and 0.01 hg; R^2 <
0.996) that was subject to PCR amplification with the
primers described above. Next, the LEDGF/p75 mRNA
levels were normalized to GAPDH mRNA levels and the
fold change was calculated for endogenous LEDGF/p75
in control cells (TC3)v sT L3-derived cell lines.
Generation of retroviral vectors
Procedures previously described were followed for the
production of the single-round infection HIV-1 reporter
virus and MLV-derived vectors [1]. Briefly, HIV-reporter
virus (HIVluc) was prepared by calcium-phosphate
cotransfection of HEK293T cells with 15 μgo fp H I V l u c
and 5 μg of pMD.G. MLV-derived vectors were produced
in Phoenix A packaging cells by calcium-phosphate
cotransfection of 15 μg of pJZLEDGF/p75 ΔPWWP and
5 μg of, pMD.G. Forty-eight hrs after transfection, the
viral supernatants were harvested. MLV-derived vectors
were further concentrated by ultracentrifugation at
124,750 g for two hrs on a 20% sucrose cushion. Viral
preparations were stored at -80°C until use.
Single-round viral infectivity assay
TL3 and LEDGF/p75-expressing TL3 cells were plated
at 1 × 10
5 cells in 500 μl of RPMI 1640 culture med-
ium in 24-well plates and infected with HIVluc viral
supernatants. Five days post-infection, cells were col-
lected by centrifugation at 1,000 × g for six mins and
the pellet lysed in 100 μl of PBS-1% Tween 20 for
15 mins on ice. Cellular lysates were centrifuged at
22,000 × g for 2 mins and supernatant used for quanti-
fication of luciferase activity. An aliquot of 20 μlo ft h e
cellular lysate supernatant was mixed with 45 μlo f
substrate (Bright-Glow™ Luciferase Assay System,
Promega) and luciferase activity was quantified using a
microplate luminometer.
Immunoblotting
Cellular lysates were resolved by SDS-PAGE and trans-
ferred overnight to PDVF membranes at 100 mAmp at
4°C. Membranes were blocked in TBS containing 10%
milk for one hour and then incubated in the corre-
sponding primary antibody diluted in TBS-5% milk-
0.05% Tween 20 (antibody dilution buffer). FLAG-
tagged LEDGF/p75 was detected with anti-FLAG Mab
(1/500, M2, Sigma) while non-tagged LEDGF/p75 was
detected with an anti-LEDGF/p75 (1/500, clone 26/
LEDGF, BD Biosciences), Myc-tagged HIV-1 integrase
was detected with anti-Myc Mab (1/500, clone 9E10,
Covance) and alpha tubulin was detected as a loading
control with anti-alpha tubulin Mab (1/4000, Clone B-5-
1-2 Sigma). Membranes were incubated overnight at 4°C
with anti-FLAG, -LEDGF, or -Myc Mabs whereas anti-
alpha tubulin Mab was incubated for two hrs at 25°C.
Primary antibody-bound membranes were washed in
TBS-0.1% Tween 20 and bound antibodies detected
with goat anti-mouse Igs-HRP (1/2000, Sigma) followed
by chemoluminescence detection. Densitometry analysis
of immunoblots was performed with the gel analysis
software UN-SCAN-IT gel 6.1 (Silkscientific).
Transient expression of LEDGF/p75 and HIV-1 integrase in
LEDGF/p75-deficient cells
LEDGF/p75-deficient 293T cells (si1340/1428 cells) [22]
were plated at 0.45 × 10
6 cells/well in a six-well plate
and transfected by calcium-phosphate with 1 ug of
FLAG-tagged LEDGF/p75 and/or Myc-eGFP-tagged
HIV-1 integrase expression plasmids. Transfected cells
showing similar eGFP levels 48 hrs after transfection
were analyzed using the salt extraction assay [13] as
described below.
Chromatin binding assay
Previously described procedures were followed [13] with
minor modifications. Briefly, cells expressing different
LEDGF/p75 mutants were lysed in CSK I or a modified
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nated by centrifugation to obtain a supernatant contain-
ing non-chromatin bound proteins (S1) and a pellet (P1)
that represents the chromatin-bound fraction. Chroma-
tin-bound proteins in P1 were further extracted from
chromatin by treatment with DNase followed by incuba-
tion in (NH4)2SO4 250 mM (S2 fraction), while the inso-
luble non-chromatin bound proteins were retained in
the pellet (P2 fraction). A total fraction (T) was obtained
by lysing the cells in 100 μl of Laemmli buffer.
Salt extraction assay
Procedures described in [13] were followed. Briefly, cells
were lysed in CSK I buffer supplemented with increas-
ing concentrations of NaCl. Cell cultures at 90% conflu-
ence were used to enrich for cells in interphase. Cellular
lysates were then fractionated by centrifugation to solu-
ble and insoluble fractions. The presence of LEDGF/p75
and/or HIV-1 integrase was determined in the soluble
fraction by immunobloting. A total fraction was
obtained by lysing the cells in Laemmli buffer.
Integrase to chromatin tethering assay
This assay was previously described [13] and is based
on the capacity of LEDGF/p75 to tether HIV-1 inte-
grase to chromatin [22]. 2LKD-IN-eGFP cells that lack
LEDGF/p75 and stably express HIV-1 integrase-eGFP
were used in this assay. Briefly, cells were plated at 2 ×
10
5 cells/chamber in 2 mls in a LabTek II chambered
coverglass and transiently transfected the next day with
LEDGF/p75 WT or mutants expression plasmids using
the calcium phosphate method. Forty-eight hrs later,
cells were fixed with 4% formaldehyde-PBS, stained
with DAPI and used for analysis of the subcellular dis-
tribution of HIV-1 IN-eGFP-LEDGF/p75 complex by
fluorescence microscopy.
Immunofluorescence
2LKD-IN-eGFP cells were transfected and fixed with 4%
formaldehyde-PBS as described above. Fixed cells were
incubated with anti-LEDGF Mab (clone 26/LEDGF, BD
Biosciences, 1/1,000 dilution) for 2 hrs at 37°C and
bound antibodies were detected by incubation with anti-
mouse Ig (H+L) coupled to Alexa Fluor 594 (10 μg/ml,
Invitrogen A21203) for 45 mins at 37°C. Finally, the
slides were stained with DAPI. The subcellular distribu-
tion of LEDGF/p75 and HIV-1 integrase proteins was
analyzed by fluorescence microscopy.
Sequencing of the MLV-transduced LEDGF/p75 cDNA
stably expressed in TL3-derived cell lines
TL3 cells were engineered to express LEDGF/p75 WT
and mutants by transduction with an MLV-derived viral
vector as previously described [1]. For sequencing the
MLV-delivered LEDGF/p75 cDNA, genomic DNA was
extracted (High pure PCR template preparation kit,
Roche) from 10
6 cells and 20 hgo fD N Aw a su s e df o r
PCR amplification with Phusion™ DNA polymerase
(Finnzymes, Inc). Primers sense MB66 (5’ TCAACGG-
GACTTTCCAAAATGTCG 3’)a n da n t i s e n s eM B 6 7( 5 ’
AGATGAACTTCAGGGTCAGC 3’)w e r ea n n e a l e da t
62°C and polymerase extension was allowed for 1.5
mins at 72°C, forty PCR cycles were performed. Next,
the PCR product was resolved on an agarose gel electro-
p h o r e s i sa n daD N Ab a n do f1 . 3K bw a si s o l a t e da n d
sequenced.
Analysis of the stability of the LEDGF/p75-HIV-1 integrase
complex
HEK293T-derived LEDGF/p75-deficient cells stably
expressing LEDGF/p75 and Myc-tagged HIV-1 integrase
were treated as described in the chromatin binding
assay to obtain the S2 fraction [13]. The S2 fraction cor-
responding to 6 × 10
6 cells was then incubated for 3 hrs
at 4°C with 300 μl of goat anti-mouse Igs-coated mag-
netic beads (Pierce) that were previously loaded with 2
μg of anti-LEDGF Mab (BD Transduction Laboratories,
catalog number 611714). Then, magnetic beads were
washed four times with CSK I buffer supplemented with
protease inhibitors (final concentration: leupeptine 2 μg/
ml, aprotinin 5 μg/μl, PMSF 1 mM, pepstatin A 1 μg/
ml) and further incubated for 15 mins on ice with
CSK I buffer containing protease inhibitors and differ-
ent concentrations of NaCl.
Immunobeads-bound and non-bound (eluate) frac-
tions were obtained by magnetic separation and ana-
lyzed by immunoblotting for LEDGF/p75 and Myc-
integrase with anti-LEDGF and anti-Myc Mabs,
respectively.
Abbreviations
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